Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Christoph Voran

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Heart Failure|December 21, 2023
Growth differentiation factor-15 in sodium-glucose cotransporter 2 inhibition: Mechanistic insights from the EMPEROR programHatim Seoudy, Jakob Christoph Voran, Derk Frank
JACC. Cardiovascular Interventions|July 10, 2025
Exponential Growth of Tricuspid Interventions in GermanyJakob Christoph Voran, Volker Rudolph, Felix Kreidel, et al.
BMC Cardiovascular Disorders|February 4, 2026
Streamlining postprocedural care after transcatheter edge-to-edge repairJakob Christoph Voran, Jan Baucks, Violetta Hachaturyan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 8, 2025
Left atrial appendage occlusion: trends in demographics and in-hospital outcomes-a German nationwide analysisJakob Christoph Voran, Hatim Seoudy, Marius Leye, et al.
British Journal of Haematology|December 19, 2022
Epidemiology of haemophagocytic lymphohistiocytosis at the population level in GermanyDavid Kuron, Jakob Christoph Voran, Friedrich Alexander von Samson-Himmelstjerna, et al.
Diagnostics (Basel, Switzerland)|December 17, 2024
Assessing Patient Health Dynamics by Comparative CT Analysis: An Automatic Approach to Organ and Body Feature EvaluationDominik Müller, Jakob Christoph Voran, Mário Macedo, et al.
Urologic Oncology|June 1, 2026
Survival association of GLP-1 receptor agonists and SGLT2 inhibitors in bladder cancer patientsJakob Kohler, Leonhard Buck, Patricia Schließer, et al.
Journal of Cardiovascular Development and Disease|January 27, 2026
First Glance at Myeloid Leukaemia Factor 2 in CardiomyocytesJakob Christoph Voran, Lucia Sophie Kilian, Simone Martini, et al.
International Journal of Cardiology. Heart & Vasculature|June 10, 2024
Transcatheter aortic valve replacement in patients with severe aortic valve stenosis and concomitant mitral valve regurgitation - 5 years follow-upRafael Henrique Rangel, Jakob Christoph Voran, Hatim Seoudy, et al.
Frontiers in Cell and Developmental Biology|November 26, 2025
Deficiency for MicroRNA-582 does not impact dilated cardiomyopathy or heart failure induced by pressure overload <i>in vivo</i>Simone Martini, Inka Dobberstein, Nesrin Schmiedel, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Heart Failure|December 21, 2023
Growth differentiation factor-15 in sodium-glucose cotransporter 2 inhibition: Mechanistic insights from the EMPEROR programHatim Seoudy, Jakob Christoph Voran, Derk Frank
JACC. Cardiovascular Interventions|July 10, 2025
Exponential Growth of Tricuspid Interventions in GermanyJakob Christoph Voran, Volker Rudolph, Felix Kreidel, et al.
BMC Cardiovascular Disorders|February 4, 2026
Streamlining postprocedural care after transcatheter edge-to-edge repairJakob Christoph Voran, Jan Baucks, Violetta Hachaturyan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 8, 2025
Left atrial appendage occlusion: trends in demographics and in-hospital outcomes-a German nationwide analysisJakob Christoph Voran, Hatim Seoudy, Marius Leye, et al.
British Journal of Haematology|December 19, 2022
Epidemiology of haemophagocytic lymphohistiocytosis at the population level in GermanyDavid Kuron, Jakob Christoph Voran, Friedrich Alexander von Samson-Himmelstjerna, et al.
Diagnostics (Basel, Switzerland)|December 17, 2024
Assessing Patient Health Dynamics by Comparative CT Analysis: An Automatic Approach to Organ and Body Feature EvaluationDominik Müller, Jakob Christoph Voran, Mário Macedo, et al.
Urologic Oncology|June 1, 2026
Survival association of GLP-1 receptor agonists and SGLT2 inhibitors in bladder cancer patientsJakob Kohler, Leonhard Buck, Patricia Schließer, et al.
Journal of Cardiovascular Development and Disease|January 27, 2026
First Glance at Myeloid Leukaemia Factor 2 in CardiomyocytesJakob Christoph Voran, Lucia Sophie Kilian, Simone Martini, et al.
International Journal of Cardiology. Heart & Vasculature|June 10, 2024
Transcatheter aortic valve replacement in patients with severe aortic valve stenosis and concomitant mitral valve regurgitation - 5 years follow-upRafael Henrique Rangel, Jakob Christoph Voran, Hatim Seoudy, et al.
Frontiers in Cell and Developmental Biology|November 26, 2025
Deficiency for MicroRNA-582 does not impact dilated cardiomyopathy or heart failure induced by pressure overload <i>in vivo</i>Simone Martini, Inka Dobberstein, Nesrin Schmiedel, et al.
Pageof 2